Glazer Capital LLC’s Trillium Therapeutics Inc. TRIL Stock Holding History

Glazer Capital LLC’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2	Closed	–	–	1217
2021 Q3	$0	Buy	+2	New	+$23	﹤0.01%	1122

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Glazer Capital LLC's TRIL Position: Q4 2021 in Review

Glazer Capital LLC sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 2 shares.

Glazer Capital LLC first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Glazer Capital LLC reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Glazer Capital LLC sold 2 Trillium Therapeutics Inc. shares in Q4 2021.
Glazer Capital LLC first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Glazer Capital LLC's Trillium Therapeutics Inc. position peaked at $0 in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Glazer Capital LLC's 13F filing for Q4 2021, filed 14 Feb 2022.